Dosing rationale for fixed-dose combinations in children: shooting from the hip?
In this investigation we evaluate the relevance of a model-based approach for pharmacokinetic (PK) bridging and dose selection of drug combinations in children. The fixed-dose combination of atovaquone (ATV) and proguanil (PGN) was used for illustration purposes. A population PK model was developed for each compound using plasma concentration data from adult and pediatric patients. PK parameter estimates were subsequently used to simulate drug exposure in children treated with different dose levels of these drugs. We show that, contrary to common practice, different dose ratios may be required across age groups in order to achieve target exposure levels comparable to adults. This example illustrates the effects of covariate interactions, specifically the ones involving body weight (BW) and ethnicity, on the PK of drugs. A model-based approach is critical for dose selection and the rational use of drug combinations in children. Flexible rather than fixed-dose ratios may be needed to ensure comparable target exposure in bridging studies.